Trinity Biotech PLC (FRA:TRB)
€ 2.12 0 (0%) Market Cap: 20.08 Mil Enterprise Value: 79.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q1 2020 Trinity Biotech PLC Earnings Call Transcript

May 27, 2020 / 03:00PM GMT
Release Date Price: €6.5 (-3.70%)
Operator

Good day, everybody, and welcome to the Trinity Biotech First Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note, today's event is being recorded. I would now like to turn the conference over to Kevin Tansley, Chief Financial Officer. Please proceed, sir.

Kevin Tansley
Trinity Biotech plc - Chief Financial & Accounting Officer, Company Secretary & Director

Thank you, Eric. Now before we begin with our prepared remarks today, we submit for the record the following statement.

Statements made by the management team of Trinity Biotech during the course of this conference call that are not historical facts are considered to be forward-looking statements subject to risks and uncertainties. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. The words believe, expect, anticipate, estimate, will and other similar statements of expectation identify those forward-looking statements.

Investors are cautioned that such forward-looking statements involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot